Search clinical trials for: JR-131
Total 2451 results
-
DualityBio Inc.Recruiting
-
Bright Cell, Inc.Not yet recruitingNasolabial Fold Wrinkles
-
Seoul National University HospitalPharos iBio Co., Ltd.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaKorea, Republic of
-
Perceive Biotherapeutics, Inc.Active, not recruitingAge-related Macular Degeneration | Geographic AtrophyUnited States
-
REGENXBIO Inc.Active, not recruitingHurler Syndrome | Hurler-Scheie Syndrome | Mucopolysaccharidosis Type I (MPS I)United States, Brazil, Israel
-
National Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Abeona Therapeutics, IncEnrolling by invitation
-
Sentien Biotechnologies, Inc.Active, not recruitingCOVID-19 | Sepsis | Acute Kidney InjuryUnited States
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedFecal Incontinence | Bowel IncontinenceUnited States
-
AstraZenecaCompletedCrohn's DiseaseUnited States, Australia
-
argenxCompletedBioavailability StudyNetherlands
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Yale UniversityWithdrawn
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Terminated
-
Boehringer IngelheimTerminatedCarcinoma, Non-Small-Cell Lung
-
HealthpointCompleted
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
TransMolecularUnknownAstrocytoma | Glioblastoma Multiforme | Malignant Glioma | GBM | OligodendrogliomaUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAlzheimer DiseaseJapan
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerTerminated
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedSchizophreniaUnited States
-
Bioray LaboratoriesChinese Academy of Medical SciencesNot yet recruiting
-
Auris Medical AGCompleted
-
MallinckrodtTerminated
-
Akros Pharma Inc.CompletedType II Diabetes MellitusUnited States, Russian Federation, Czech Republic, Hungary, Netherlands
-
University of NottinghamCompleted
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Peking Union Medical College HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Stealth BioTherapeutics Inc.CompletedAge-related Macular DegenerationUnited States
-
Tianjin ConjuStar Biologics Co., Ltd.Recruiting
-
Hangzhou Jiayin Biotech LtdRecruiting
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingModerate-to-Severe Plaque PsoriasisChina
-
Ankyra Therapeutics, IncRecruitingSolid Tumor | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Malignant Solid Tumor | Cutaneous Tumor | Subcutaneous Tumor | Metastasis to Soft TissueUnited States, Canada
-
DualityBio Inc.RecruitingAdvanced Solid TumorsUnited States, Australia
-
Betta Pharmaceuticals Co., Ltd.Recruiting
-
Aardvark Therapeutics, Inc.Children's Hospital Colorado; Stanford UniversityRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
CorrectSequence Therapeutics Co., LtdFirst Affiliated Hospital of Guangxi Medical UniversityActive, not recruiting
-
Blue Blood Biotech Corp.Completed
-
Paean Biotechnology Inc.CompletedDermatomyositis | PolymyositisKorea, Republic of
-
Imperial College LondonNucanaCompleted
-
Agalimmune Ltd.CompletedSuperficial, Palpable, Unresectable/Metastatic Solid TumourUnited States, Israel, United Kingdom
-
REGENXBIO Inc.Active, not recruitingMucopolysaccharidosis Type II (MPS II)United States, Brazil
-
Fervent PharmaceuticalsICON plcCompletedVasomotor Symptoms | MenopauseUnited States
-
Asklepios Biopharmaceutical, Inc.Active, not recruiting
-
Dr. Anupam SehgalTaysha Gene Therapies, Inc.; GlycoNetActive, not recruitingInfantile GM2 Gangliosidosis (Disorder)Canada
-
Innovo Therapeutics, Inc.Completed